Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoral vs Tacrolimus in Liver Transplant Recipients with Recurrent Hepatitis C
NCT00938860Phase 4Completed
- Sponsor
- Novartis
- Start
- Sep 2009
- Primary completion
- May 2013
- Modality
- Peptides, Small Molecules
- Countries
- 13
01
Overview
A Phase 4 trial of cyclosporine microemulsion in hepatitis C (HCV), sponsored by Novartis. Started Sep 2009; status: completed.
02
Drugs
cyclosporine microemulsion
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00938860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00938860.